StonvexLoading…
StonvexStonvexStonvexCore line items from NVVE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.79M | $5.29M | $8.33M | $5.37M |
Operating Income | $-32.18M | $-20.46M | $-32.11M | $-36.92M |
Net Income | $-30.82M | $-17.40M | $-31.28M | $-24.02M |
EPS (Diluted) | $-75.65 | $-1076.70 | $-403.57 | $-47.55 |
Total Assets | $17.39M | $16.80M | $20.95M | $41.20M |
Total Liabilities | $14.86M | $18.09M | $13.96M | $13.96M |
Cash & Equivalents | $5.47M | $371.50K | $1.53M | $15.75M |
Free Cash Flow OCF − CapEx | $-16.68M | $-15.78M | $-21.44M | $-34.52M |
Shares Outstanding | 2.07M | 22.58K | 124.66K | 606.80K |